Neohemocyte
| Cardiology Network |
 Discuss Neohemocyte further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Neohemocyte ("new blood cell") is the name given by its University of California at San Francisco creators to artificial red blood cells. These cells are created by packing natural hemoglobin molecules in fat bubbles made from phospholipids and cholesterol, resulting in cells roughly one-twelfth the size of human erythrocytes. They provide an advantage over real blood cells in their longer storage capacity (about six months versus 35 days).[1]
References
- ↑ Marieb, Elaine Nicpon. Human Anatomy & Physiology. 4th ed. Menlo Park, California: Addison Wesley Longman, Inc. 1998. 650.